Viatris VTRS
NASDAQ VTRS
$16.51 -0.10 (-0.60%)
As of: Sep 9, 2026 · 2:29 PM EDT

Viatris (VTRS) Accounts Payables (2019 - 2026)

Viatris (VTRS) posted Accounts Payables of $1.7 billion for Q2 2026, down 1.31% on a QoQ basis from $1.7 billion in Q1 2026, and down 3.15% year-over-year from $1.8 billion in Q2 2025.

Analysis

Viatris (VTRS) Accounts Payables (2019 - 2026) Analysis & Trends

Viatris has reported Accounts Payables for 8 years, with the latest figure at $1.7 billion in Q2 2026.

  • On a quarterly basis, Accounts Payables fell 3.15% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 3.15% decrease from a year earlier, with the FY2025 full-year figure at $1.8 billion, down 5.37% from the prior year.
  • Accounts Payables was $1.7 billion for Q2 2026 at Viatris, down from $1.7 billion in the prior quarter.
  • The five-year high for Accounts Payables was $2.2 billion in Q1 2024, with the low at $1.3 billion in Q3 2022.
  • Average Accounts Payables over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Accounts Payables retreated 26.61% in 2022, then jumped 51.78% in 2023.
  • Over 5 years, Accounts Payables stood at $1.8 billion in 2022, then climbed by 9.71% to $1.9 billion in 2023, then slipped by 4.36% to $1.9 billion in 2024, then decreased by 5.37% to $1.8 billion in 2025, then fell by 1.57% to $1.7 billion in 2026.
  • The last three Accounts Payables figures came in at $1.7 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Teva Pharmaceutical Industries 42.57 Bn 38.91 Bn 2.15 Bn 2.72 Bn
2 Viatris 19.20 Bn 18.31 Bn 1.46 Bn 1.73 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 396.07 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 721.21 Mn
5 Bausch Health Companies 2.36 Bn 520.75 Mn 2.10 Bn 593.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 133.16 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 73.83 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn 251.37 Mn
9 Fennec Pharmaceuticals 406.25 Mn 365.00 Mn 17.15 Mn 5.52 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn - 731,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.73 Bn
Mar 31, 2026 1.75 Bn
Dec 31, 2025 1.75 Bn
Sep 30, 2025 1.79 Bn
Jun 30, 2025 1.78 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 1.85 Bn
Sep 30, 2024 1.93 Bn
Jun 30, 2024 1.96 Bn
Mar 31, 2024 2.20 Bn
Dec 31, 2023 1.94 Bn
Sep 30, 2023 1.99 Bn
Jun 30, 2023 1.96 Bn
Mar 31, 2023 1.96 Bn
Dec 31, 2022 1.77 Bn
Sep 30, 2022 1.31 Bn
Jun 30, 2022 1.67 Bn
Mar 31, 2022 1.50 Bn
Dec 31, 2021 1.66 Bn
Sep 30, 2021 1.66 Bn